Sanuwave Adds to Board

Alpharetta, Ga.-based Sanuwave Health Inc. has named Alan L. Rubino to its board of directors. Rubino has more than 30 years of experience in the biopharmaceutical industry, including positions focused on sales and marketing and U.S. Securities and Exchange Commission (SEC) matters. With this appointment, the company’s board has four members.

Rubino has served as president and CEO of Emisphere Technologies Inc. since September 2012. Previously, he served as president and CEO of New American Therapeutics Inc., president and CEO of Akrimax Pharmaceuticals LLC, and president and chief operating officer of Pharmos Corporation. Rubino also has worked at Hoffmann-La Roche Inc., where he was a member of the U.S. Executive and Operating committees and an SEC corporate officer. During his tenure at Hoffmann-LaRoche, he held executive positions in marketing, sales, business operations, supply chain and human resource management, and was assigned executive committee roles in marketing, project management, and globalization.

Sanuwave develops non-invasive devices for the repair and regeneration of tissue, musculoskeletal and vascular structures.